These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 27743568)

  • 21. Approach to the Solitary Liver Lesion: Imaging and When to Biopsy.
    Pang EH; Harris AC; Chang SD
    Can Assoc Radiol J; 2016 May; 67(2):130-48. PubMed ID: 26702758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR characterization of focal liver lesions: pearls and pitfalls.
    Siegelman ES; Chauhan A
    Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):295-313. PubMed ID: 25086931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Pathologic Grade.
    Huang X; Xiao Z; Zhang Y; Lin N; Xiong M; Huang X; Chen Q; Cao D
    J Comput Assist Tomogr; 2018; 42(3):365-372. PubMed ID: 29369947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR imaging of benign focal liver lesions.
    Cogley JR; Miller FH
    Radiol Clin North Am; 2014 Jul; 52(4):657-82. PubMed ID: 24889166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a novel time-efficient protocol for gadobenate dimeglumine (Gd-BOPTA)-enhanced liver magnetic resonance imaging.
    Schneider G; Altmeyer K; Kirchin MA; Seidel R; Grazioli L; Morana G; Saini S
    Invest Radiol; 2007 Feb; 42(2):105-15. PubMed ID: 17220728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Part 2: MRI of hypervascular focal liver lesions using liver specific contrast agents.
    Sutherland T; Seale M; Yap K
    J Med Imaging Radiat Oncol; 2014 Feb; 58(1):56-63. PubMed ID: 24529056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous gadolinium-based hepatocyte-specific contrast agents (HSCAs) for contrast-enhanced liver magnetic resonance imaging in pediatric patients: what the radiologist should know.
    Ayyala RS; Anupindi SA; Gee MS; Trout AT; Callahan MJ
    Pediatr Radiol; 2019 Sep; 49(10):1256-1268. PubMed ID: 31350632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver Mass Evaluation in Patients Without Cirrhosis: A Technique-Based Method.
    Liu PS
    Radiol Clin North Am; 2015 Sep; 53(5):903-18. PubMed ID: 26321445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic magnetic resonance imaging: new techniques and contrast agents.
    Mahfouz AE; Hamm B; Taupitz M
    Endoscopy; 1997 Aug; 29(6):504-14. PubMed ID: 9342568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of hepatic hemangiomas at contrast-enhanced harmonic US.
    Albrecht T; Blomley MJ
    Radiology; 2001 Jul; 220(1):269-70. PubMed ID: 11426009
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of MRI with hepatospecific contrast agent in the identification and characterization of focal liver lesions: pathological correlation in explanted livers.
    Orlacchio A; Chegai F; Fabiano S; Merolla S; Funel V; Di Giuliano F; Manuelli M; Tisone G; Francioso S; Angelico M; Palmieri G; Simonetti G
    Radiol Med; 2016 Jul; 121(7):588-96. PubMed ID: 27100719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of magnetic resonance imaging contrast agents in the liver and biliary tract.
    Lebedis C; Luna A; Soto JA
    Magn Reson Imaging Clin N Am; 2012 Nov; 20(4):715-37. PubMed ID: 23088947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-enhanced ultrasound (CEUS) for the evaluation of focal liver lesions - a prospective multicenter study of its usefulness in clinical practice.
    Sporea I; Badea R; Popescu A; Spârchez Z; Sirli RL; Dănilă M; Săndulescu L; Bota S; Calescu DP; Nedelcu D; Brisc C; Ciobâca L; Gheorghe L; Socaciu M; Martie A; Ioaniţescu S; Tamas A; Streba CT; Iordache M; Simionov I; Jinga M; Anghel A; Cijevschi Prelipcean C; Mihai C; Stanciu SM; Stoicescu D; Dumitru E; Pietrareanu C; Bartos D; Manzat Saplacan R; Pârvulescu I; Vădan R; Smira G; Tuţă L; Săftoiu A
    Ultraschall Med; 2014 Jun; 35(3):259-66. PubMed ID: 24563420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-gated 4D-MRI of the liver: Initial clinical results of continuous multiphase imaging of hepatic enhancement.
    Weiss J; Notohamiprodjo M; Martirosian P; Taron J; Nickel MD; Kolb M; Bamberg F; Nikolaou K; Othman AE
    J Magn Reson Imaging; 2018 Feb; 47(2):459-467. PubMed ID: 28594113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
    Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
    Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visibility of focal liver lesions: Comparison between kupffer phase of CEUS with sonazoid and hepatobiliary phase of gadoxetic acid-enhanced MRI.
    Yang WY; Park HS; Kim YJ; Yu MH; Jung SI; Jeon HJ
    J Clin Ultrasound; 2017 Nov; 45(9):542-550. PubMed ID: 28547764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous Hepatic Arterial Multiphase Magnetic Resonance Imaging During Free-Breathing.
    Weiss J; Notohamiprodjo M; Taron J; Martirosian P; Nickel D; Bamberg F; Nikolaou K; Othman AE
    Invest Radiol; 2018 Oct; 53(10):596-601. PubMed ID: 29494350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiation of hypointense nodules on gadoxetic acid-enhanced hepatobiliary-phase MRI using T
    Yoneyama M; Takayama Y; Nishie A; Nakamura M; Katsumata Y; Takemura A; Obara M; Okuaki T; Honda H; Van Cauteren M
    Eur J Radiol; 2017 Oct; 95():325-331. PubMed ID: 28987688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
    Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
    Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal liver lesion detection and characterization with GD-EOB-DTPA.
    Purysko AS; Remer EM; Veniero JC
    Clin Radiol; 2011 Jul; 66(7):673-84. PubMed ID: 21524416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.